Dr Imran Ahmad

  • Clinical Senior Lecturer/Honorary Consultant (Beatson Institute for Cancer Research)

Research interests

I am currently a Clinical Senior Lecturer and CRUK Clinician Scientist in Uro-Oncology at the CRUK: Beatson Institute and the Institute for Cancer Sciences at the University of Glasgow.  I carried out my PhD (2007-2011) at the Beatson under the supervision of Professors Owen J Sansom and Hing Y Leung, looking at the role of Wnt signalling in bladder cancer (funded by the MRC and CRUK).  My current research interest is in understanding the mechanisms of treatment resistance in advanced prostate cancer.  As part of the Urology Group at the Beatson, work in my laboratory uses novel in vivo models in conjunction with patient samples to interrogate the disease processes in advanced and treatment resistant prostate cancer.
In addition, I am also a Honorary Consultant Urological and Robotic Surgeon in the NHS Greater Glasgow and Clyde.  Based at the Queen Elizabeth University Hospital (QEUH) in Glasgow, I am one of the highest volume Robotic Prostatectomists in the United Kingdom.  I have also recently introduced Robotic Radical Cystectomy for High Risk/Muscle Invasive Bladder Cancer to the West of Scotland.
 

Awards & Prizes

2018   American Urological Association and BAUS Visiting Scholar Programme Winner
2017   Chairman’s Award at NHS GG&C (Introduction of Robotic Prostatectomy Service)
2017   EAU Best Paper on Fundamental Research
2014   ARTP Award 2014 (L'Association pour la Recherche sur les Tumeurs  de la Prostate)
2013   Thomas and Margaret Smellie Prize (Best PhD thesis by a medical graduate) – University of Glasgow
2013   Hunterian Professorship – Royal College of Surgeons of England
2013   EAU Prostate Cancer Research Award 2013
2012   The Royal Medico - Chirurgical Society of Glasgow Prize,
2012   EAU Best Poster Prize – (Urothelial Tumours – Basic Research), EAU 2012, Paris
2012   EAU Best Poster Prize – (Prostate Cancers – Basic Research), EAU 2012, Paris
2012   Celtic Urology Network Prize – Celtic Urology Network Meeting, Edinburgh
2011   Sir James Black Medal - Scottish Society of Experimental Medicine


Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Identification and Validation of New Therapeutic Targets in Enzalutamide-Resistant Prostate Cancer
    Cancer Research UK
    2016 - 2021
     

Publications

List by: Type | Date

Jump to: 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006
Number of items: 50.

2018

Ahmad, I. and Sansom, O. J. (2018) Role of Wnt signalling in advanced prostate cancer. Journal of Pathology, 245, pp. 3-5. (doi:10.1002/path.5029) (PMID:29314004)

Galbraith, L., Leung, H. Y. and Ahmad, I. (2018) Lipid pathway deregulation in advanced prostate cancer. Pharmacological Research, 131, pp. 177-184. (doi:10.1016/j.phrs.2018.02.022) (PMID:29466694)

Patel, R. et al. (2018) Sprouty2 loss‐induced IL6 drives castration‐resistant prostate cancer through scavenger receptor B1. EMBO Molecular Medicine, 10(4), e8347. (doi:10.15252/emmm.201708347) (PMID:29540470)

Salji, M., Hendry, J., Patel, A., Ahmad, I. , Nixon, C. and Leung, H. Y. (2018) Peri-prostatic fat volume measurement as a predictive tool for castration resistance in advanced prostate cancer. European Urology Focus, (doi:10.1016/j.euf.2017.01.019) (PMID:28753854) (Early Online Publication)

2017

Loveridge, C. J. et al. (2017) Analysis of Nkx3.1:Cre-driven Erk5 deletion reveals a profound spinal deformity which is linked to increased osteoclast activity. Scientific Reports, 7, 13241. (doi:10.1038/s41598-017-13346-8) (PMID:29038439) (PMCID:PMC5643304)

Loveridge, C. J. et al. (2017) Increased T cell infiltration elicited by Erk5 deletion in a Pten-deficient mouse model of prostate carcinogenesis. Cancer Research, 77(12), pp. 3158-3168. (doi:10.1158/0008-5472.CAN-16-2565) (PMID:28515147)

Tan, W. S., Lamb, B. W., Tan, M.-Y., Ahmad, I. , Sridhar, A., Nathan, S., Hines, J., Shaw, G., Briggs, T. P. and Kelly, J. D. (2017) In-depth critical analysis of complications following robot-assisted radical cystectomy with intracorporeal urinary diversion. European Urology Focus, 3(2-3), pp. 273-279. (doi:10.1016/j.euf.2016.06.002) (PMID:28753745)

2016

Lamb, B. W. et al. (2016) Benefits of robotic cystectomy with intracorporeal diversion for patients with low cardiorespiratory fitness: a prospective cohort study. Urologic Oncology: Seminars and Original Investigations, 34(9), 417.e17-417.e23. (doi:10.1016/j.urolonc.2016.04.006) (PMID:27197920)

Ahmad, I. et al. (2016) Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer. Proceedings of the National Academy of Sciences of the United States of America, 113(29), pp. 8290-8295. (doi:10.1073/pnas.1601571113) (PMID:27357679) (PMCID:PMC4961202)

2015

Loveridge, C., Mui, E., Ahmad, I. , Welsh, M., Tan, E., Fleming, J., Sansom, O. and Leung, H. (2015) The Role of Erk5 in Prostate Carcinogenesis. In: 11th World Congress on Urological Research, Nijmegen, The Nertherlands, September 2015, (Unpublished)

2014

Rajan, P. et al. (2014) Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy. European Urology, 66(1), pp. 32-39. (doi:10.1016/j.eururo.2013.08.011) (PMID:24054872) (PMCID:PMC4062940)

Stockley, J., Villasevil, M. E. M., Nixon, C., Ahmad, I. , Leung, H. and Rajan, P. (2014) The RNA-binding protein hnRNPA2 regulates β-catenin protein expression and is overexpressed in prostate cancer. RNA Biology, 11(6), pp. 755-765. (doi:10.4161/rna.28800) (PMID:24823909) (PMCID:PMC4156506)

2013

Patel, R. et al. (2013) Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression. Journal of Clinical Investigation, 123(3), pp. 1157-1175. (doi:10.1172/JCI63672)

Ahmad, I. , Gao, M., Patel, R. and Leung, H.Y. (2013) Modelling synergistic interactions between HER2, Sprouty2 and PTEN in driving prostate carcinogenesis. Asian Journal of Andrology, 15(3), pp. 323-327. (doi:10.1038/aja.2013.40)

Ahmad, I. et al. (2013) Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancer. British Journal of Cancer, 108(1), pp. 149-154. (doi:10.1038/bjc.2012.510)

Yang, Z., Laird, A., Monaghan, A., Seywright, M., Ahmad, I. and Leung, H.Y. (2013) Incidental seminal vesicle amyloidosis observed in diagnostic prostate biopsies—are routine investigations for systemic amyloidosis warranted? Asian Journal of Andrology, 15(1), pp. 149-151. (doi:10.1038/aja.2012.125)

2012

Ahmad, I. , Iwata, T. and Leung, H.Y. (2012) Mechanisms of FGFR-mediated carcinogenesis. Biochimica et Biophysica Acta: Molecular Cell Research, 1823(4), pp. 850-860. (doi:10.1016/j.bbamcr.2012.01.004)

McCall, P. et al. (2012) NFκB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression. British Journal of Cancer, 107(9), pp. 1554-1563. (doi:10.1038/bjc.2012.372)

2011

Armstrong, K., Ahmad, I. , Kalna, G., Tan, S.S., Edwards, J. , Robson, C.N. and Leung, H.Y. (2011) Upregulated FGFR1 expression is associated with the transition of hormone-naive to castrate-resistant prostate cancer. British Journal of Cancer, 105(9), pp. 1362-1369. (doi:10.1038/bjc.2011.367)

Ahmad, I. , Singh, L.B., Foth, M., Morris, C.-A., Taketo, M.M., Wu, X.-R., Leung, H.Y. , Sansom, O.J. and Iwata, T. (2011) K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder. Disease Models and Mechanisms, 4(4), pp. 548-555. (doi:10.1242/dmm.006874)

Ahmad, I. , Patel, R., Liu, Y., Singh, L.B., Taketo, M.M., Wu, X.-R., Leung, H.Y. and Sansom, O.J. (2011) Ras mutation cooperates with β-catenin activation to drive bladder tumourigenesis. Cell Death and Disease, 2, e124. (doi:10.1038/cddis.2011.7)

Tan, S.S., Ahmad, I. , Bennett, H.L., Singh, L., Nixon, C., Seywright, M., Barnetson, R.J., Edwards, J. and Leung, H. (2011) GRP78 up-regulation is associated with androgen receptor status, Hsp70-Hsp90 client proteins and castrate-resistant prostate cance. Journal of Pathology, 223(1), pp. 81-87. (doi:10.1002/path.2795) (PMID:21125667)

Ahmad, I. et al. (2011) β-Catenin activation synergizes with PTEN loss to cause bladder cancer formation. Oncogene, 30(2), pp. 178-189. (doi:10.1038/onc.2010.399)

Ahmad, I. et al. (2011) HER2 overcomes PTEN (loss)-induced senescence to cause aggressive prostate cancer. Proceedings of the National Academy of Sciences of the United States of America, 108(39), pp. 16392-16397. (doi:10.1073/pnas.1101263108)

Ramsay, A.K. et al. (2011) ERK5 signalling in prostate cancer promotes an invasive phenotype. British Journal of Cancer, 104(4), pp. 664-672. (doi:10.1038/sj.bjc.6606062)

2010

Ahmad, I. and Sansom, O.J. (2010) Today’s research: tomorrow’s therapies. Future Oncology, 6(7), pp. 1095-1097. (doi:10.2217/fon.10.77)

2009

Ahmad, I. , Krishna, N.S., Small, D.R. and Conn, I.G. (2009) Aetiology and management of acute female urinary retention. British Journal of Medical and Surgical Urology, 2(1), pp. 27-33. (doi:10.1016/j.bjmsu.2008.10.004)

Ahmad, I. , Sansom, O.J. and Leung, H.Y. (2009) The role of murine models of prostate cancer in drug target discovery and validation. Expert Opinion on Drug Discovery, 4(8), pp. 879-888. (doi:10.1517/17460440903049308)

Nelson, A.W., Ahmad, I. , Pickard, R.S. and Leung, H.Y. (2009) The new BAUS section of academic urology: a survey of the urological community. British Journal of Medical and Surgical Urology, 2(4), pp. 147-153. (doi:10.1016/j.bjmsu.2009.04.003)

2008

Ahmad, I. , Sarath Krishna, N., Small, D.R. and Conn, I.G. (2008) Management of female urinary retention: an 11 year experience. BJU International, 101(S5), p. 29.

Ahmad, I. , Sarath Krishna, N. and Meddings, R.N. (2008) Sequential hydrodistension and intravesical instillation of hyaluronic acid under general anaesthesia for treatment of refractory interstitial cystitis: a pilot study. International Urogynecology Journal, 19(4), pp. 543-546. (doi:10.1007/s00192-007-0443-4)

Ahmad, I. , Barnetson, R.J. and Krishna, N.S. (2008) Keratinizing squamous metaplasia of the bladder: a review. Urologia Internationalis, 81(3), pp. 247-51.

Ahmad, I. , Sansom, O.J. and Leung, H.Y. (2008) Advances in mouse models of prostate cancer. Expert Reviews in Molecular Medicine, 10, e16. (doi:10.1017/S1462399408000689)

Ahmad, I. , Small, D.R. and Granitsiotis, P. (2008) The role of ultrasound for the measurement of bladder volume. Urology News, 12(2), pp. 10-13.

2007

Ahmad, I. and Patil, S. (2007) Isolated deep peroneal (fibular) nerve palsy in association with primary total hip arthroplasty. Clinical Anatomy, 20(6), pp. 703-704. (doi:10.1002/ca.20468)

Ahmad, I. , Sarath Krishna, N., Clark, R., Al-Saffar, N. and Nairn, R. (2007) Interval development of testicular carcinoma in patients with previously demonstrated testicular microlithiasis. BJU International, 99(S4), p. 51.

Ahmad, I. , Sarath Krishna, N., Small, D.R., Morrison, L. and Akhtar, M.N. (2007) CT urogram as an initial investigation in Frank haematuria. BJU International, 99(S4), p. 22.

Ahmad, I. and Krishna, N.S. (2007) Hemospermia. Journal of Urology, 177(5), pp. 1613-1618.

Ahmad, I. , Sarath Krishna, N., Small, D.R., Morrison, L. and Akhtar, M.N. (2007) Prostate cancer incidence in patients on finasteride for lower urinary tract symptoms. European Urology Supplements, 6(2), p. 177. (doi:10.1016/S1569-9056(07)60615-0)

Ahmad, I. , Sarath Krishna, N. and Meddings, R.N. (2007) Role of EMLA cream in biopsy and excision of penile lesions. Annals of the Royal College of Surgeons of England, 89(1), p. 73. (doi:10.1308/rcsann.2007.89.1.73a) (PMCID:PMC1963559)

Ahmad, I. (2007) Change in functional status of patients whilst awaiting primary total knee arthroplasty. Surgeon, 5(5), pp. 266-267. (doi:10.1016/S1479-666X(07)80022-9)

Ahmad, I. , Adlard, P., Duncan, P., Bunyan, D.J., Harvey, J., Tolmie, J. and Donaldson, M.D.C. (2007) A novel mutation of DAX-1 with an atypical presentation of X-linked adrenal hypoplasia congenita. Hormone Research, 68, pp. 32-37.

Ahmad, I. and Granitsiotis, P. (2007) Urological follow-up of adult spina bifida patients. Neurourology and Urodynamics, 26(7), pp. 978-980.

Ahmad, I. , Hilmy, M., Small, D.R. and Conn, I.G. (2007) Is urethroplasty a feasible long-term solution for urethral stricture? Journal of Urology, 177(S4), pp. 13-14.

Ahmad, I. , Krishna, N.S., Clark, R., Nairn, R. and Al-Saffar, N. (2007) Testicular microlithiasis: prevalence and risk of concurrent and interval development of testicular tumor in a referred population. International Urology and Nephrology, 39(4), pp. 1177-1181. (doi:10.1007/s11255-007-9203-0)

Ahmad, I. , Paterson, W.F., Lin, L., Adlard, P., Duncan, P. and Donaldson, M.D.C. (2007) A novel missense mutation in Dax-1 with an unusual presentation of X-linked adrenal hypoplasia congenita. Hormone Research, 68(1), pp. 32-37. (doi:10.1159/000099835)

Ahmad, I. , Sarath Krishna, N., Clark, R., Al-Saffar, N. and Nairn, R. (2007) Interval development of testicular carcinoma in patients with previously demonstrated testicular microlithiasis. Journal of Urology, 177(S4), p. 400.

Ahmad, I. , Sarath Krishna, N. and Meddings, R.N. (2007) Role of hydrodistension and intravesical instillation of cystistat for resistant interstitial cystitis. Journal of Urology, 177(S4), p. 47.

Ahmad, I. , Sarath Krishna, N., Small, D.R., Morrison, L. and Akhtar, M.N. (2007) Prostate cancer incidence in patients on finasteride for lower urinary tract symptoms. Journal of Urology, 177(S4), p. 75.

2006

Ahmad, I. , Sarath Krishna, N. and Meddings, R.N. (2006) Role of hydrodistension and intravesical instillation of cystistat for resistant interstitial cystitis. BJU International, 97(S3), p. 34.

This list was generated on Sun Dec 16 14:08:30 2018 GMT.
Number of items: 50.

Articles

Ahmad, I. and Sansom, O. J. (2018) Role of Wnt signalling in advanced prostate cancer. Journal of Pathology, 245, pp. 3-5. (doi:10.1002/path.5029) (PMID:29314004)

Galbraith, L., Leung, H. Y. and Ahmad, I. (2018) Lipid pathway deregulation in advanced prostate cancer. Pharmacological Research, 131, pp. 177-184. (doi:10.1016/j.phrs.2018.02.022) (PMID:29466694)

Patel, R. et al. (2018) Sprouty2 loss‐induced IL6 drives castration‐resistant prostate cancer through scavenger receptor B1. EMBO Molecular Medicine, 10(4), e8347. (doi:10.15252/emmm.201708347) (PMID:29540470)

Salji, M., Hendry, J., Patel, A., Ahmad, I. , Nixon, C. and Leung, H. Y. (2018) Peri-prostatic fat volume measurement as a predictive tool for castration resistance in advanced prostate cancer. European Urology Focus, (doi:10.1016/j.euf.2017.01.019) (PMID:28753854) (Early Online Publication)

Loveridge, C. J. et al. (2017) Analysis of Nkx3.1:Cre-driven Erk5 deletion reveals a profound spinal deformity which is linked to increased osteoclast activity. Scientific Reports, 7, 13241. (doi:10.1038/s41598-017-13346-8) (PMID:29038439) (PMCID:PMC5643304)

Loveridge, C. J. et al. (2017) Increased T cell infiltration elicited by Erk5 deletion in a Pten-deficient mouse model of prostate carcinogenesis. Cancer Research, 77(12), pp. 3158-3168. (doi:10.1158/0008-5472.CAN-16-2565) (PMID:28515147)

Tan, W. S., Lamb, B. W., Tan, M.-Y., Ahmad, I. , Sridhar, A., Nathan, S., Hines, J., Shaw, G., Briggs, T. P. and Kelly, J. D. (2017) In-depth critical analysis of complications following robot-assisted radical cystectomy with intracorporeal urinary diversion. European Urology Focus, 3(2-3), pp. 273-279. (doi:10.1016/j.euf.2016.06.002) (PMID:28753745)

Lamb, B. W. et al. (2016) Benefits of robotic cystectomy with intracorporeal diversion for patients with low cardiorespiratory fitness: a prospective cohort study. Urologic Oncology: Seminars and Original Investigations, 34(9), 417.e17-417.e23. (doi:10.1016/j.urolonc.2016.04.006) (PMID:27197920)

Ahmad, I. et al. (2016) Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer. Proceedings of the National Academy of Sciences of the United States of America, 113(29), pp. 8290-8295. (doi:10.1073/pnas.1601571113) (PMID:27357679) (PMCID:PMC4961202)

Rajan, P. et al. (2014) Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy. European Urology, 66(1), pp. 32-39. (doi:10.1016/j.eururo.2013.08.011) (PMID:24054872) (PMCID:PMC4062940)

Stockley, J., Villasevil, M. E. M., Nixon, C., Ahmad, I. , Leung, H. and Rajan, P. (2014) The RNA-binding protein hnRNPA2 regulates β-catenin protein expression and is overexpressed in prostate cancer. RNA Biology, 11(6), pp. 755-765. (doi:10.4161/rna.28800) (PMID:24823909) (PMCID:PMC4156506)

Patel, R. et al. (2013) Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression. Journal of Clinical Investigation, 123(3), pp. 1157-1175. (doi:10.1172/JCI63672)

Ahmad, I. , Gao, M., Patel, R. and Leung, H.Y. (2013) Modelling synergistic interactions between HER2, Sprouty2 and PTEN in driving prostate carcinogenesis. Asian Journal of Andrology, 15(3), pp. 323-327. (doi:10.1038/aja.2013.40)

Ahmad, I. et al. (2013) Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancer. British Journal of Cancer, 108(1), pp. 149-154. (doi:10.1038/bjc.2012.510)

Yang, Z., Laird, A., Monaghan, A., Seywright, M., Ahmad, I. and Leung, H.Y. (2013) Incidental seminal vesicle amyloidosis observed in diagnostic prostate biopsies—are routine investigations for systemic amyloidosis warranted? Asian Journal of Andrology, 15(1), pp. 149-151. (doi:10.1038/aja.2012.125)

Ahmad, I. , Iwata, T. and Leung, H.Y. (2012) Mechanisms of FGFR-mediated carcinogenesis. Biochimica et Biophysica Acta: Molecular Cell Research, 1823(4), pp. 850-860. (doi:10.1016/j.bbamcr.2012.01.004)

McCall, P. et al. (2012) NFκB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression. British Journal of Cancer, 107(9), pp. 1554-1563. (doi:10.1038/bjc.2012.372)

Armstrong, K., Ahmad, I. , Kalna, G., Tan, S.S., Edwards, J. , Robson, C.N. and Leung, H.Y. (2011) Upregulated FGFR1 expression is associated with the transition of hormone-naive to castrate-resistant prostate cancer. British Journal of Cancer, 105(9), pp. 1362-1369. (doi:10.1038/bjc.2011.367)

Ahmad, I. , Singh, L.B., Foth, M., Morris, C.-A., Taketo, M.M., Wu, X.-R., Leung, H.Y. , Sansom, O.J. and Iwata, T. (2011) K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder. Disease Models and Mechanisms, 4(4), pp. 548-555. (doi:10.1242/dmm.006874)

Ahmad, I. , Patel, R., Liu, Y., Singh, L.B., Taketo, M.M., Wu, X.-R., Leung, H.Y. and Sansom, O.J. (2011) Ras mutation cooperates with β-catenin activation to drive bladder tumourigenesis. Cell Death and Disease, 2, e124. (doi:10.1038/cddis.2011.7)

Tan, S.S., Ahmad, I. , Bennett, H.L., Singh, L., Nixon, C., Seywright, M., Barnetson, R.J., Edwards, J. and Leung, H. (2011) GRP78 up-regulation is associated with androgen receptor status, Hsp70-Hsp90 client proteins and castrate-resistant prostate cance. Journal of Pathology, 223(1), pp. 81-87. (doi:10.1002/path.2795) (PMID:21125667)

Ahmad, I. et al. (2011) β-Catenin activation synergizes with PTEN loss to cause bladder cancer formation. Oncogene, 30(2), pp. 178-189. (doi:10.1038/onc.2010.399)

Ahmad, I. et al. (2011) HER2 overcomes PTEN (loss)-induced senescence to cause aggressive prostate cancer. Proceedings of the National Academy of Sciences of the United States of America, 108(39), pp. 16392-16397. (doi:10.1073/pnas.1101263108)

Ramsay, A.K. et al. (2011) ERK5 signalling in prostate cancer promotes an invasive phenotype. British Journal of Cancer, 104(4), pp. 664-672. (doi:10.1038/sj.bjc.6606062)

Ahmad, I. and Sansom, O.J. (2010) Today’s research: tomorrow’s therapies. Future Oncology, 6(7), pp. 1095-1097. (doi:10.2217/fon.10.77)

Ahmad, I. , Krishna, N.S., Small, D.R. and Conn, I.G. (2009) Aetiology and management of acute female urinary retention. British Journal of Medical and Surgical Urology, 2(1), pp. 27-33. (doi:10.1016/j.bjmsu.2008.10.004)

Ahmad, I. , Sansom, O.J. and Leung, H.Y. (2009) The role of murine models of prostate cancer in drug target discovery and validation. Expert Opinion on Drug Discovery, 4(8), pp. 879-888. (doi:10.1517/17460440903049308)

Nelson, A.W., Ahmad, I. , Pickard, R.S. and Leung, H.Y. (2009) The new BAUS section of academic urology: a survey of the urological community. British Journal of Medical and Surgical Urology, 2(4), pp. 147-153. (doi:10.1016/j.bjmsu.2009.04.003)

Ahmad, I. , Sarath Krishna, N., Small, D.R. and Conn, I.G. (2008) Management of female urinary retention: an 11 year experience. BJU International, 101(S5), p. 29.

Ahmad, I. , Sarath Krishna, N. and Meddings, R.N. (2008) Sequential hydrodistension and intravesical instillation of hyaluronic acid under general anaesthesia for treatment of refractory interstitial cystitis: a pilot study. International Urogynecology Journal, 19(4), pp. 543-546. (doi:10.1007/s00192-007-0443-4)

Ahmad, I. , Barnetson, R.J. and Krishna, N.S. (2008) Keratinizing squamous metaplasia of the bladder: a review. Urologia Internationalis, 81(3), pp. 247-51.

Ahmad, I. , Sansom, O.J. and Leung, H.Y. (2008) Advances in mouse models of prostate cancer. Expert Reviews in Molecular Medicine, 10, e16. (doi:10.1017/S1462399408000689)

Ahmad, I. , Small, D.R. and Granitsiotis, P. (2008) The role of ultrasound for the measurement of bladder volume. Urology News, 12(2), pp. 10-13.

Ahmad, I. and Patil, S. (2007) Isolated deep peroneal (fibular) nerve palsy in association with primary total hip arthroplasty. Clinical Anatomy, 20(6), pp. 703-704. (doi:10.1002/ca.20468)

Ahmad, I. , Sarath Krishna, N., Clark, R., Al-Saffar, N. and Nairn, R. (2007) Interval development of testicular carcinoma in patients with previously demonstrated testicular microlithiasis. BJU International, 99(S4), p. 51.

Ahmad, I. , Sarath Krishna, N., Small, D.R., Morrison, L. and Akhtar, M.N. (2007) CT urogram as an initial investigation in Frank haematuria. BJU International, 99(S4), p. 22.

Ahmad, I. and Krishna, N.S. (2007) Hemospermia. Journal of Urology, 177(5), pp. 1613-1618.

Ahmad, I. , Sarath Krishna, N., Small, D.R., Morrison, L. and Akhtar, M.N. (2007) Prostate cancer incidence in patients on finasteride for lower urinary tract symptoms. European Urology Supplements, 6(2), p. 177. (doi:10.1016/S1569-9056(07)60615-0)

Ahmad, I. , Sarath Krishna, N. and Meddings, R.N. (2007) Role of EMLA cream in biopsy and excision of penile lesions. Annals of the Royal College of Surgeons of England, 89(1), p. 73. (doi:10.1308/rcsann.2007.89.1.73a) (PMCID:PMC1963559)

Ahmad, I. (2007) Change in functional status of patients whilst awaiting primary total knee arthroplasty. Surgeon, 5(5), pp. 266-267. (doi:10.1016/S1479-666X(07)80022-9)

Ahmad, I. , Adlard, P., Duncan, P., Bunyan, D.J., Harvey, J., Tolmie, J. and Donaldson, M.D.C. (2007) A novel mutation of DAX-1 with an atypical presentation of X-linked adrenal hypoplasia congenita. Hormone Research, 68, pp. 32-37.

Ahmad, I. and Granitsiotis, P. (2007) Urological follow-up of adult spina bifida patients. Neurourology and Urodynamics, 26(7), pp. 978-980.

Ahmad, I. , Hilmy, M., Small, D.R. and Conn, I.G. (2007) Is urethroplasty a feasible long-term solution for urethral stricture? Journal of Urology, 177(S4), pp. 13-14.

Ahmad, I. , Krishna, N.S., Clark, R., Nairn, R. and Al-Saffar, N. (2007) Testicular microlithiasis: prevalence and risk of concurrent and interval development of testicular tumor in a referred population. International Urology and Nephrology, 39(4), pp. 1177-1181. (doi:10.1007/s11255-007-9203-0)

Ahmad, I. , Paterson, W.F., Lin, L., Adlard, P., Duncan, P. and Donaldson, M.D.C. (2007) A novel missense mutation in Dax-1 with an unusual presentation of X-linked adrenal hypoplasia congenita. Hormone Research, 68(1), pp. 32-37. (doi:10.1159/000099835)

Ahmad, I. , Sarath Krishna, N., Clark, R., Al-Saffar, N. and Nairn, R. (2007) Interval development of testicular carcinoma in patients with previously demonstrated testicular microlithiasis. Journal of Urology, 177(S4), p. 400.

Ahmad, I. , Sarath Krishna, N. and Meddings, R.N. (2007) Role of hydrodistension and intravesical instillation of cystistat for resistant interstitial cystitis. Journal of Urology, 177(S4), p. 47.

Ahmad, I. , Sarath Krishna, N., Small, D.R., Morrison, L. and Akhtar, M.N. (2007) Prostate cancer incidence in patients on finasteride for lower urinary tract symptoms. Journal of Urology, 177(S4), p. 75.

Ahmad, I. , Sarath Krishna, N. and Meddings, R.N. (2006) Role of hydrodistension and intravesical instillation of cystistat for resistant interstitial cystitis. BJU International, 97(S3), p. 34.

Conference Proceedings

Loveridge, C., Mui, E., Ahmad, I. , Welsh, M., Tan, E., Fleming, J., Sansom, O. and Leung, H. (2015) The Role of Erk5 in Prostate Carcinogenesis. In: 11th World Congress on Urological Research, Nijmegen, The Nertherlands, September 2015, (Unpublished)

This list was generated on Sun Dec 16 14:08:30 2018 GMT.